» Articles » PMID: 36839903

Formulation of Miconazole-Loaded Chitosan-Carbopol Vesicular Gel: Optimization to In Vitro Characterization, Irritation, and Antifungal Assessment

Overview
Journal Pharmaceutics
Publisher MDPI
Date 2023 Feb 25
PMID 36839903
Authors
Affiliations
Soon will be listed here.
Abstract

Miconazole nitrate (MN) is a poorly water-soluble and antifungal drug used for fungal infections. The present research work was designed to develop topical MN-loaded bilosomes (BSs) for the improvement of therapeutic efficacy. MZBSs were prepared by using the thin-film hydration method and further optimized by using the Box-Behnken statistical design (BBD). The optimized miconazole bilosome (MZBSo) showed nano-sized vesicles, a low polydispersity index, a high entrapment efficiency, and zeta potential. Further, MZBSo was incorporated into the gel using carbopol 934P and chitosan polymers. The selected miconazole bilosome gel (MZBSoG2) demonstrated an acceptable pH (6.4 ± 0.1), viscosity (1856 ± 21 cP), and spreadability (6.6 ± 0.2 cm). Compared to MZBSo (86.76 ± 3.7%), MZBSoG2 showed a significantly ( < 0.05) slower drug release (58.54 ± 4.1%). MZBSoG2 was found to be a non-irritant because it achieved a score of zero (standard score) in the HET-CAM test. It also exhibited significant antifungal activity compared to pure MZ against and . The stability study results showed no significant changes after stability testing under accelerated conditions. MZ-loaded gels could serve as effective alternative carriers for improving therapeutic efficacy.

Citing Articles

The Pharmaceutical and Pharmacological Potential Applications of Bilosomes as Nanocarriers for Drug Delivery.

Mitrovic D, Zaklan D, danic M, Stanimirov B, Stankov K, Al-Salami H Molecules. 2025; 30(5).

PMID: 40076403 PMC: 11901966. DOI: 10.3390/molecules30051181.


Formulation and Evaluation of a Silymarin Inclusion Complex-Based Gel for Skin Cancer.

Mahdi W, Imam S, Alotaibi A, Alhallaf S, Alzhrani R, Alshehri S ACS Omega. 2025; 10(3):3006-3017.

PMID: 39895738 PMC: 11780436. DOI: 10.1021/acsomega.4c09614.


Optimizing lornoxicam-loaded poly(lactic-co-glycolic acid) and (polyethylene glycol) nanoparticles for transdermal delivery: / inflammation evaluation.

Qaiser R, Pervaiz F, Noreen S, Hanan H, Shoukat H, Mahmood H Nanomedicine (Lond). 2024; 19(16):1471-1485.

PMID: 38953843 PMC: 11318691. DOI: 10.1080/17435889.2024.2359356.


Emerging Trends in Bilosomes as Therapeutic Drug Delivery Systems.

Kaurav H, Tripathi M, Kaur S, Bansal A, Kapoor D, Sheth S Pharmaceutics. 2024; 16(6).

PMID: 38931820 PMC: 11206586. DOI: 10.3390/pharmaceutics16060697.


The anti-fungal effect of miconazole and miconazole-loaded chitosan nanoparticles gels in diabetic patients with Oral candidiasis-randomized control clinical trial and microbiological analysis.

Gamil Y, Hamed M, Elsayed M, Essawy A, Medhat S, Zayed S BMC Oral Health. 2024; 24(1):196.

PMID: 38321454 PMC: 10848391. DOI: 10.1186/s12903-024-03952-0.


References
1.
Mohsen A, Hasanein Asfour M, Salama A . Improved hepatoprotective activity of silymarin via encapsulation in the novel vesicular nanosystem bilosomes. Drug Dev Ind Pharm. 2017; 43(12):2043-2054. DOI: 10.1080/03639045.2017.1361968. View

2.
El-Nabarawi M, Shamma R, Farouk F, Nasralla S . Bilosomes as a novel carrier for the cutaneous delivery for dapsone as a potential treatment of acne: preparation, characterization and skin deposition assay. J Liposome Res. 2019; 30(1):1-11. DOI: 10.1080/08982104.2019.1577256. View

3.
Al-Mahallawi A, Abdelbary A, Aburahma M . Investigating the potential of employing bilosomes as a novel vesicular carrier for transdermal delivery of tenoxicam. Int J Pharm. 2015; 485(1-2):329-40. DOI: 10.1016/j.ijpharm.2015.03.033. View

4.
Marwah H, Garg T, Goyal A, Rath G . Permeation enhancer strategies in transdermal drug delivery. Drug Deliv. 2014; 23(2):564-78. DOI: 10.3109/10717544.2014.935532. View

5.
Barot B, Parejiya P, Patel H, Gohel M, Shelat P . Microemulsion-based gel of terbinafine for the treatment of onychomycosis: optimization of formulation using D-optimal design. AAPS PharmSciTech. 2011; 13(1):184-92. PMC: 3299475. DOI: 10.1208/s12249-011-9742-7. View